dipyridamole has been researched along with Acquired Immunodeficiency Syndrome in 7 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipyridamole (DP) is a widely used coronary vasodilator and antithrombotic drug." | 2.38 | [A new drug in a new role: dipyridamole in the treatment of HIV-1 infections?]. ( Szebeni, J, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Requena, L | 1 |
| Fariña, C | 1 |
| Barat, A | 1 |
| Mitsuya, H | 1 |
| Yarchoan, R | 1 |
| Kageyama, S | 1 |
| Broder, S | 1 |
| Szebeni, J | 2 |
| Weinstein, JN | 1 |
| Bunow, B | 1 |
| Weislow, OS | 1 |
| Schinazi, RF | 1 |
| Wahl, SM | 1 |
| Wahl, LM | 1 |
| Magnani, M | 1 |
| Bianchi, M | 1 |
| Rossi, L | 1 |
| Stocchi, V | 1 |
| Wyngaarden, JB | 1 |
| Ullman, B | 1 |
| Coons, T | 1 |
| Rockwell, S | 1 |
| McCartan, K | 1 |
3 reviews available for dipyridamole and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Targeted therapy of human immunodeficiency virus-related disease.
Topics: Acquired Immunodeficiency Syndrome; Adenine; Antiviral Agents; CD4 Antigens; Didanosine; Dideoxynucl | 1991 |
[A new drug in a new role: dipyridamole in the treatment of HIV-1 infections?].
Topics: Acquired Immunodeficiency Syndrome; Dipyridamole; Drug Therapy, Combination; HIV Infections; HIV-1; | 1991 |
Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general.
Topics: Acquired Immunodeficiency Syndrome; Dideoxynucleosides; Dipyridamole; Drug Synergism; Drug Therapy, | 1990 |
4 other studies available for dipyridamole and Acquired Immunodeficiency Syndrome
| Article | Year |
|---|---|
Degos disease in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Atrophy; Cicatrix; Dipyridamole; Erythema; Homosexuality, Male; | 1998 |
2',3'-dideoxycytidine permeation of the human erythrocyte membrane.
Topics: Acquired Immunodeficiency Syndrome; Biological Transport; Diffusion; Dipyridamole; Erythrocyte Membr | 1989 |
From the National Institutes of Health.
Topics: Acquired Immunodeficiency Syndrome; Carcinoma; Colorectal Neoplasms; Dipyridamole; Humans; Interfero | 1989 |
Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
Topics: Acquired Immunodeficiency Syndrome; Biological Transport; Cell Division; Cell Survival; Deoxycytidin | 1988 |